VE-cadherin effects on proliferation of metastatic mammary cancer cells, which were previously attributed to the TGFβ pathway [14], could also be explained with the outside-in α2β1 integrin activation and the subsequent activation of the SRC, ERK and JNK pathways. The gene discussed is CDH5; the disease is breast cancer.